InflaRx to Present at Upcoming J.P. Morgan Annual Healthcare Conference Jena, Germany, January 9, 2020- InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, will present at the J.P. Morgan 38thAnnual Healthcare Conference being held January 13-16, 2020 at the Westin St. Francis Hotel in San Francisco, CA, USA. Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, will give a corporate presentation on Thursday, January 16that 9:30 am PST (12:30 pm EST/6:30 pm CET). A live webcastof the presentation will be provided on the...
|
